May 12, 2021|
JD Pharmacy Celebrates 5th Anniversary with Over 170 Brands
by Hui Zhang
JD Health held a brand partner conference in Beijing gathering more than 170 pharmaceutical brands from around the world on May 11 to mark the 5th anniversary of JD Pharmacy, the first-party pharmaceutical business model of JD Health. The company announced the launching of Single Disease Patient Care Centers under JD Pharmacy at the conference.
Through the care centers, users will have easy access to drugs for a specific disease and can enjoy a one-stop professional and personalized medical services. There will be a total of nine single disease patient care centers established in the first batch, includes centers focusing on diabetes, hepatitis, and a nutrition clinic.
“JD Health hopes to improve patient compliance through specialized and professional operations, based on providing scientific diagnosis and treatment to patients. Patients will benefit from scientific and professional medical services, and our partners will benefit from being able to provide meticulous and reasonable services to consumers,” said Enlin Jin, vice president of JD Health and general manager of the company’s medicine business.
Enlin Jin, vice president of JD Health and general manager of the company’s medicine business
In addition to the care center, JD Health together with vcbeat.top, a Chinese service organization providing industry research, released a report on pharmaceutical e-commerce industrial trends at the conference. According to the report shared by Han Hao, the senior researcher from vcbeat.top, continuous expansion of the pharmaceutical business, offering omni-channel services, and innovating marketing solutions are among the key factors influencing the future development of the industry.
JD Health started its pharmaceutical e-commerce business in January 2016 by setting up a platform for third-party pharmaceutical retail and opened JD Pharmacy the same year to run its first-party pharmaceutical business. The company has been constantly expanding its pharmaceutical business through cooperation with brand partners. So far, it has established cooperation with 46 of the global Top 50 and 97 of Chinese Top 100 pharmaceutical companies, such as Eisai China, AstraZeneca, Pfizer, Novartis, Bristol-Myers Squibb (BMS), Sanofi and Abbott Laboratories.
A list of brand partners
In March 2021, JD Health started providing ‘self-operated cold chain’ services to partners to guarantee drug safety and customer convenience. In addition to timely delivery services, JD health also offers online healthcare services connecting hospitals, doctors and other healthcare professionals such as pharmacists, nutritionists and psychological counselors with its users to provide them with comprehensive services.
Leveraging its technology and big data strengths, JD Health is working with pharmaceutical companies to explore innovative marketing solutions to enhance sales, and many of its partners, such as Eisai, Novartis, and AstraZeneca, chose to debut their new drugs on JD Health.
“As the core platform of the pharmaceutical supply chain business segment of JD Health, from 2016-2021, JD Pharmacy has grown from a pharmaceutical retail business into an influential, online and offline integrated pharmaceutical retail and marketing platform,” said Lijun Xin, CEO of JD Health.